Emyria (EMD) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Emyria to plug $2.5M into depression treatment program at Empax CentreNovember 26, 2024 | msn.comEmyria Limited Plans Major Securities IssuanceNovember 26, 2024 | tipranks.comHealth Check: Actinogen powers ahead with key Alzheimer’s disease trialNovember 14, 2024 | msn.comEmyria Limited Announces Successful AGM ResolutionsNovember 11, 2024 | tipranks.comEmyria, UWA seek commercialisation of compounds to treat PTSD and Parkinson'sOctober 31, 2024 | msn.comEmyria Ltd Announces Key Growth and Innovation MilestonesOctober 30, 2024 | markets.businessinsider.comEmyria Gains Key Endorsement for Psychedelic TherapiesOctober 28, 2024 | msn.comEmyria Ltd Ordinary SharesOctober 22, 2024 | morningstar.comInsider Spends AU$300k Buying More Shares In EmyriaSeptember 25, 2024 | finance.yahoo.comAlive and Kicking: Lumos Diagnostics attracts ‘Twiggy’ Forrest as cornerstone holder in $10m raiseSeptember 3, 2024 | msn.comEmyria Full Year 2024 Earnings: AU$0.032 loss per share (vs AU$0.018 loss in FY 2023)September 1, 2024 | finance.yahoo.comUS March deficit shrinks as outlays fall, tax receipts riseApril 11, 2024 | finance.yahoo.comEmyria opens Empax Centre to target care gaps in resistant PTSDApril 10, 2024 | finance.yahoo.comEmyria Slides As Insider Purchases Lose Another AU$300kJanuary 29, 2024 | finance.yahoo.comEmyria kicks off year with $2.5 million R&D incentive on the heels of Authorised Prescriber statusJanuary 14, 2024 | au.investing.comSEC gives Bitcoin ETFs the long-awaited green lightJanuary 10, 2024 | proactiveinvestors.com.auEmyria sharpens focus on delivering MDMA treatments for PTSD patientsJanuary 10, 2024 | proactiveinvestors.com.auClosing Bell: The ASX got slow-boiled like a frog in a pot to close at -0.69pc downJanuary 10, 2024 | msn.comASX Health Stocks: Emyria surges 19pc after granting of ‘Authorised Prescriber’ status by TGAJanuary 9, 2024 | msn.comEmyria welcomes top healthcare leader as chairmanNovember 21, 2023 | proactiveinvestors.com.auEmyria restructures board amid cost efficiency commitmentNovember 12, 2023 | proactiveinvestors.com.auIt's Unlikely That Shareholders Will Increase Emyria Limited's (ASX:EMD) Compensation By Much This YearNovember 9, 2023 | finance.yahoo.comEmyria secures ethics endorsement for MDMA Authorised Prescriber application, clearing way for TGA decisionOctober 30, 2023 | proactiveinvestors.com.auEmyria hails strong growth in clinical billingsOctober 26, 2023 | finance.yahoo.comEmyria given green light to import MDMA for therapeutic trials in AustraliaOctober 21, 2023 | proactiveinvestors.com.auEmyria completes entitlement offer, raises $1.18m ahead of MDMA-assisted therapy trialOctober 5, 2023 | au.investing.comEmyria set to begin MDMA study after securing local supplySeptember 26, 2023 | finance.yahoo.comEmyria provides unique combination of drug development and therapy deliverySeptember 7, 2023 | finance.yahoo.comClosing Bell: Liontown’s kitty is sitting pretty; Benchmark makes most of Monday ahead of RBA meetSeptember 4, 2023 | msn.comEmyria raises $2 million in placement; launches $3.1 million entitlement offerSeptember 4, 2023 | proactiveinvestors.com.auTop 10 at 11: Emyria soars on funding news, and loads of tasty stuff unearthed in Canada.September 3, 2023 | msn.comEmyria Full Year 2023 Earnings: AU$0.018 loss per share (vs AU$0.027 loss in FY 2022)September 1, 2023 | finance.yahoo.comEmyria advances development and commercialisation of unique drug productsAugust 1, 2023 | finance.yahoo.comEmyria recruits first patient for MDMA-assisted therapy trialJuly 11, 2023 | proactiveinvestors.com.auEmyria expands mental health care capabilities with Pax Centre acquisitionJuly 3, 2023 | proactiveinvestors.com.auEmyria hails ethics approval for MDMA-assisted clinical trialJune 8, 2023 | proactiveinvestors.com.auEmyria gains ethics approval for landmark MDMA-assisted PTSD therapy trialJune 7, 2023 | proactiveinvestors.com.auEmyria completes $2.5M placement to advance MDMA-assisted therapyMay 1, 2023 | proactiveinvestors.com.auEmyria Limited (EMD.AX)April 29, 2023 | au.finance.yahoo.comEmyria launches new high potency Ultra-Pure CBD capsuleApril 24, 2023 | proactiveinvestors.com.auEmyria expands CBD pipeline with launch of highest potency Ultra-Pure CBD capsuleApril 24, 2023 | proactiveinvestors.com.auEmyria extends PAX partnership to develop psilocybin-assisted therapy care modelApril 17, 2023 | proactiveinvestors.com.auEmyria agrees licensing and commercialisation deal for EMD-RX5April 4, 2023 | proactiveinvestors.com.auEmyria and pharma company Aspen Australia ink agreement to license and commercialise EMD-RX5 as OTC anxiety medicationApril 3, 2023 | proactiveinvestors.com.auEmyria experiences high patient demand as it enrols for Phase 3 trial of OTC treatment for stress and anxietyMarch 22, 2023 | proactiveinvestors.com.auEmyria and UWA expand MDMA analogue library to target neurological and mental health conditionsMarch 19, 2023 | proactiveinvestors.com.auEmyria thrilled with new collaboration for MDMA-assisted PTSD therapyMarch 7, 2023 | proactiveinvestors.com.auEmyria collaborates with psychiatrist-led clinical service in MDMA-assisted therapy for PTSDMarch 6, 2023 | proactiveinvestors.com.auASX Health Stocks: Emyria partners with Pax Centre to provide psychedelics therapy for PTSD sufferersMarch 6, 2023 | msn.comMalcolm Washer Just Bought 1.7% More Shares In Emyria Limited (ASX:EMD)February 25, 2023 | uk.finance.yahoo.com Get Emyria News Delivered to You Automatically Sign up to receive the latest news and ratings for EMD and its competitors with MarketBeat's FREE daily newsletter. Email Address This is the worst sign for the U.S. stock market in 50 years (Ad)The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone" Click here to see Dan's new, urgent warning about the U.S. market for 2025. EMD Media Mentions By Week EMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EMD News Sentiment▼0.000.60▲Average Medical News Sentiment EMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EMD Articles This Week▼00▲EMD Articles Average Week Get Emyria News Delivered to You Automatically Sign up to receive the latest news and ratings for EMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aclarion News Today BrightSpring Health Services News Today Bullfrog AI News Today Cannabis Sativa News Today CareCloud News Today CareCloud News Today CloudMD Software & Services News Today CompuGroup Medical SE & Co. KGaA News Today eWellness Healthcare News Today HeartBeam News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:EMD) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredThis Warning flashed just before the dot-com bust and the Great DepressionA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emyria Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Emyria With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EMD Stock Alerts